COVID19 (Corona virus disease).ppt

COVID19 (Corona virus disease).ppt

• 1.
  Mr. PANDURANG B.PAWAR Assistant Professor & Head, Department of Microbiology, Shri Vyankatesh Arts, Commerce and Science College, Deulgaon Raja- 443204 Maharashtra, India https://svcdrajamicrobiology.blogspot.com/
• 2.
  INTRODUCTION Corona viruses (CoV)are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel corona virus (nCoV) is a new strain that has not been previously identified in humans.
• 3.
  Origin Wuhan City, HubeiProvince, China.
• 4.
  STRUCTURE OF SARS-COV2
• 5.
  SIGNS AND SYMPTOMS FeverCoughing Sour Throat Difficulty Breathing
• 6.
  COVID-19 TRANSMISSION Droplet-spread diseasescan be spread by: Coughing and sneezing or talks. Close personal contact Contact with an object or surface with viral particles on it and then touching your mouth, nose or eyes.
• 7.
  PREVENTION AND CONTROL Youshould always practice good hygiene A healthy lifestyle. Tips for people living with or affected by non- communicable diseases (NCDs)
• 8.
  RISK FACTORS& CONDITIONS Smokers Peoplewith underlying medical conditions, such as a compromised immune system, liver disease, cancer, kidney disease, heart disease and diabetes mellitus, need to take more precautions.
• 9.
  DIAGNOSTIC TESTING Real Time(RT)-PCR of Throat and Nasal Swab Rapid antibody kits.
• 10.
  DRUG THERAPY Chloroquine Hydroxychloroquine. Remdesivir, Lopinavir&Ritonavir Azithromycin Tocilizumab COVID-19 convalescent plasma.
• 11.
  REFERENCES • https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-novel- coronavirus-health-advice-general-public/covid-19-novel-coronavirus-questions-and-answers • https://www.who.int/internal-publications-detail/covid-19-and-ncds •https://www.nytimes.com/interactive/2020/03/17/learning/News-Quiz-Coronavirus.html • https://icmr.nic.in/sites/default/files/upload_documents/Guidance_on_RapidKits_COVID19_28032020_V1.p df • World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected https://www.who.int/publicationsdetail/clinical-management-of- severe-acute-respiratory-infection-when-novel-coronavirus- (ncov)-infection-is-suspectedn • CDC Website: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidancemanagement-patients.html. • FDA Website: https://www.fda.gov/emergency-preparedness-and-response/mcmissues/coronavirus-disease- 2019-covid-19 • https://www.elsevier.com/__data/assets/pdf_file/0007/988648/COVID-19-Drug-Therapy_Mar-2020.pdf
• 12.
  Thank You